Pharmaceutical company UNIMED, owned by its founder Ridha Charfeddine, announced that it had achieved a turnover of 31.1 million dinars in the first quarter of 2019, against 13.9 million a year earlier, representing a growth of 124%.
This increase affected both the local market and the export market.
In fact, the local turnover rose 122% to 18.2 million dinars while exports reached 12.9 million dinars, up 126% from the first quarter of 2018.
At March 31, 2019, investments (intangible & tangible) amounted to 4 MTD, consisting mainly of plant extension work for 1.5 MTD, rolling stock for 1.4 MTD, and industrial equipment for 0.7 MDT.
Concerning long-term debt, as of March 31, 2019 it amounts to 21 MTD including a new release of 4.8 MTD under the bank loan for the financing of the extension of the factory.
Short-term debt increased by 37%, mainly due to new leasing loans that were contacted in 2018 and early 2019.